SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-17-121536
Filing Date
2017-04-12
Accepted
2017-04-12 17:26:05
Documents
9
Period of Report
2017-06-06

Document Format Files

Seq Description Document Type Size
1 PRE 14A d366780dpre14a.htm PRE 14A 269151
3 GRAPHIC g366780g06z51.jpg GRAPHIC 28348
4 GRAPHIC g366780g23f54.gif GRAPHIC 4326
5 GRAPHIC g366780g95u36.jpg GRAPHIC 26780
6 GRAPHIC g366780pc01anew.jpg GRAPHIC 33964
7 GRAPHIC g366780pc01b.jpg GRAPHIC 61926
8 GRAPHIC g366780pc01c.jpg GRAPHIC 23438
9 GRAPHIC g366780pc01d.jpg GRAPHIC 30893
10 GRAPHIC g366780pc01e.jpg GRAPHIC 55323
  Complete submission text file 0001193125-17-121536.txt   634922
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36304 | Film No.: 17758652
SIC: 2834 Pharmaceutical Preparations